J. Goldman & CO LP Amgen Inc Put Options Transaction History

J. Goldman & CO LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $6.19 Million - $6.75 Million	20,000 New	20,000 $6.44 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $4.57 Million - $5.52 Million	17,000 Added 566.67%	20,000 $5.69 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $9.46 Million - $10.7 Million	-37,000 Reduced 92.5%	3,000 $864,000
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $8.75 Million - $10.9 Million	40,000 New	40,000 $10.8 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.